These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 18541344
1. Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study. Kumakura Y, Vernaleken I, Buchholz HG, Borghammer P, Danielsen E, Gründer G, Heinz A, Bartenstein P, Cumming P. Neurobiol Aging; 2010 Mar; 31(3):447-63. PubMed ID: 18541344 [Abstract] [Full Text] [Related]
2. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity. Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P. J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292 [Abstract] [Full Text] [Related]
3. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography. Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, Gjedde A, Cumming P. Synapse; 1999 Sep 15; 33(4):247-58. PubMed ID: 10421705 [Abstract] [Full Text] [Related]
4. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. Kumakura Y, Cumming P. Neuroscientist; 2009 Dec 15; 15(6):635-50. PubMed ID: 19793723 [Abstract] [Full Text] [Related]
5. Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects. Vernaleken I, Kumakura Y, Buchholz HG, Siessmeier T, Hilgers RD, Bartenstein P, Cumming P, Gründer G. Neuroimage; 2008 Apr 15; 40(3):1222-31. PubMed ID: 18262797 [Abstract] [Full Text] [Related]
6. Loss of metabolites from monkey striatum during PET with FDOPA. Cumming P, Munk OL, Doudet D. Synapse; 2001 Sep 01; 41(3):212-8. PubMed ID: 11391782 [Abstract] [Full Text] [Related]
7. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms. Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P. J Cereb Blood Flow Metab; 2006 Mar 01; 26(3):358-70. PubMed ID: 16079784 [Abstract] [Full Text] [Related]
8. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Vernaleken I, Kumakura Y, Cumming P, Buchholz HG, Siessmeier T, Stoeter P, Müller MJ, Bartenstein P, Gründer G. Neuroimage; 2006 May 01; 30(4):1332-9. PubMed ID: 16439159 [Abstract] [Full Text] [Related]
9. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects. Rousset OG, Deep P, Kuwabara H, Evans AC, Gjedde AH, Cumming P. Synapse; 2000 Aug 01; 37(2):81-9. PubMed ID: 10881028 [Abstract] [Full Text] [Related]
10. Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease. Kumakura Y, Danielsen EH, Gjedde A, Vernaleken I, Buchholz HG, Heinz A, Gründer G, Bartenstein P, Cumming P. Neuroimage; 2010 Feb 15; 49(4):2933-9. PubMed ID: 19941962 [Abstract] [Full Text] [Related]
11. Increased turnover of dopamine in caudate nucleus of detoxified alcoholic patients. Kumakura Y, Gjedde A, Caprioli D, Kienast T, Beck A, Plotkin M, Schlagenhauf F, Vernaleken I, Gründer G, Bartenstein P, Heinz A, Cumming P. PLoS One; 2013 Feb 15; 8(9):e73903. PubMed ID: 24040111 [Abstract] [Full Text] [Related]
12. Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway. Matsubara K, Watabe H, Kumakura Y, Hayashi T, Endres CJ, Minato K, Iida H. Synapse; 2011 Aug 15; 65(8):751-62. PubMed ID: 21190220 [Abstract] [Full Text] [Related]
13. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study. Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, Kienast T, Bartenstein P, Gründer G. J Neurosci; 2007 Jul 25; 27(30):8080-7. PubMed ID: 17652599 [Abstract] [Full Text] [Related]
14. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria. Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, Zepp F, Ullrich K. J Cereb Blood Flow Metab; 2008 Apr 25; 28(4):824-31. PubMed ID: 17971791 [Abstract] [Full Text] [Related]
15. Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study. Schabram I, Henkel K, Mohammadkhani Shali S, Dietrich C, Schmaljohann J, Winz O, Prinz S, Rademacher L, Neumaier B, Felzen M, Kumakura Y, Cumming P, Mottaghy FM, Gründer G, Vernaleken I. J Neurosci; 2014 Oct 29; 34(44):14769-76. PubMed ID: 25355228 [Abstract] [Full Text] [Related]
17. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. Deep P, Dagher A, Sadikot A, Gjedde A, Cumming P. Synapse; 1999 Dec 15; 34(4):313-8. PubMed ID: 10529725 [Abstract] [Full Text] [Related]
18. Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]DOPA. Ota M, Yasuno F, Ito H, Seki C, Nozaki S, Asada T, Suhara T. Life Sci; 2006 Jul 17; 79(8):730-6. PubMed ID: 16580023 [Abstract] [Full Text] [Related]
19. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects. Kuwabara H, Cumming P, Reith J, Léger G, Diksic M, Evans AC, Gjedde A. J Cereb Blood Flow Metab; 1993 Jan 17; 13(1):43-56. PubMed ID: 8417009 [Abstract] [Full Text] [Related]
20. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB. Psychiatry Res; 2008 Jul 15; 163(2):171-82. PubMed ID: 18504119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]